XML 39 R26.htm IDEA: XBRL DOCUMENT v3.4.0.3
Financial Instruments Measured at Fair Value (Tables)
3 Months Ended
Apr. 02, 2016
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block]
The following table presents assets (liabilities) measured at fair value on a recurring basis at April 2, 2016:
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available-for-sale securities
 
38,537

 

 

 
38,537

Interest rate swaps
 

 
1,952

 

 
1,952

Foreign exchange contracts
 

 
(1,731
)
 

 
(1,731
)
 
 
$
38,537

 
$
221

 
$

 
$
38,758



The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2015:
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available-for-sale securities
 
$
41,178

 
$

 
$

 
$
41,178

Interest rate swaps
 

 
711

 

 
711

Foreign exchange contracts
 

 
(738
)
 

 
(738
)
Contingent consideration
 

 

 
(3,889
)
 
(3,889
)
 
 
$
41,178

 
$
(27
)
 
$
(3,889
)
 
$
37,262

Available-for-sale Securities [Text Block]
The fair value of the company's available-for-sale securities is as follows:
 
 
April 2, 2016
 
December 31, 2015
  
 
Marubun
 
Mutual Funds
 
Marubun
 
Mutual Funds
Cost basis
 
$
10,016

 
17,423

 
$
10,016

 
17,389

Unrealized holding gain
 
6,027

 
5,071

 
8,708

 
5,065

Fair value
 
$
16,043

 
$
22,494

 
$
18,724

 
$
22,454



Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Text Block]
The fair values of derivative instruments in the company's consolidated balance sheets are as follows:
 
 
Asset (Liability) Derivatives
  
 
  
 
Fair Value
  
 
Balance Sheet
Location
 
April 2,
2016
 
December 31,
2015
Derivative instruments designated as hedges:
 
 
 
 
 
 
Interest rate swaps designated as fair value hedges
 
Other liabilities
 
$

 
$

Interest rate swaps designated as fair value hedges
 
Other assets
 
1,952

 
711

Foreign exchange contracts designated as cash flow hedges
 
Other current assets
 

 
896

Foreign exchange contracts designated as cash flow hedges
 
Accrued expenses
 
(1,836
)
 
(572
)
Total derivative instruments designated as hedging instruments
 
 
 
116

 
1,035

Derivative instruments not designated as hedges:
 
 
 
 

 
 

Foreign exchange contracts
 
Other current assets
 
2,271

 
1,729

Foreign exchange contracts
 
Accrued expenses
 
(2,166
)
 
(2,791
)
Total derivative instruments not designated as hedging instruments
 
 
 
105

 
(1,062
)
Total
 
 
 
$
221

 
$
(27
)
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]
The effect of derivative instruments on the company's consolidated statements of operations is as follows:
 
 
Gain (Loss) Recognized in Income
  

Quarter Ended
  
 
April 2,
2016
 
March 28,
2015
Derivative instruments not designated as hedges:
 
 
 
 
Foreign exchange contracts (a)
 
$
(2,237
)
 
$
808

  Total
 
$
(2,237
)
 
$
808


 
 
Cash Flow Hedges
 
 
Interest Rate Swaps (b)
 
Foreign Exchange Contracts (c)
Quarter Ended April 2, 2016
 
 
 
 
Effective portion:
 
 
 
 
Gain (loss) recognized in other comprehensive income
 
$

 
$
(846
)
Loss reclassified into income
 
$
(149
)
 
$
(1,202
)
Ineffective portion:
 
 
 
 
Gain (loss) recognized in income
 
$

 
$

 
 
 
 
 
Quarter Ended March 28, 2015
 
 
 
 
Effective portion:
 
 
 
 
Gain recognized in other comprehensive income
 
$
827

 
$
2,682

Loss reclassified into income
 
$
(161
)
 
$
(841
)
Ineffective portion:
 
 
 
 
Gain (loss) recognized in income
 
$
69

 
$



(a)
The amount of gain (loss) recognized in income on derivatives is recorded in "Cost of sales" in the company's consolidated statements of operations.
(b)
Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Interest and other financing expense, net" in the company's consolidated statements of operations. The gain (loss) amounts reclassified into income relate to the termination of swaps.
(c)
Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Cost of sales" in the company's consolidated statements of operations.